Metabolic reprogramming mediates hippocampal microglial M1 polarization in response to surgical trauma causing

Gang Luo1, Xiaofeng Wang1, Yongchen Cui1

  • 1Department of Anesthesiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiaotong University, 600 Yishan Road, Shanghai, 200233, China.

Abstract

Insights

Surgical trauma triggers metabolic changes in the brain, promoting inflammation and cognitive decline in aged mice. Inhibiting this metabolic shift with 2-deoxy-D-glucose (2-DG) can reduce neuroinflammation and improve cognitive function, offering a potential treatment for postoperative neurocognitive disorders (PNDs).

Area of Science:

  • Neuroscience
  • Metabolic Biology
  • Immunology

Background:

  • Pro-inflammatory M1 microglial polarization contributes significantly to perioperative neurocognitive disorders (PNDs).
  • Metabolic reprogramming is a key regulator of microglial polarization.
  • Surgical trauma is hypothesized to induce M1 polarization via metabolic reprogramming, leading to neuroinflammation and cognitive impairment.

Purpose of the Study:

  • To investigate if surgical trauma induces metabolic reprogramming in the aged mouse hippocampus.
  • To determine the effect of the glycolytic inhibitor 2-deoxy-D-glucose (2-DG) on microglial polarization, neuroinflammation, and cognitive function post-surgery.

Main Methods:

  • Aged mice were used to model PNDs.
  • Positron emission tomography/computed tomography (PET/CT) and gas chromatography/time-of-flight mass spectrometry (GC/TOF-MS) metabolomic analyses were employed.
  • The impact of 2-DG on hippocampal microglia, neuroinflammation markers, and cognitive function was assessed 3 days after surgery.

Main Results:

  • Surgical trauma led to increased M1 microglial markers (iNOS/CD86) and neuroinflammation in the hippocampus, accompanied by a shift from oxidative phosphorylation to glycolysis.
  • 2-DG treatment significantly reduced M1 polarization and pro-inflammatory mediator expression (IL-1β, IL-6).
  • Inhibition of glycolysis by 2-DG ameliorated surgery-induced, hippocampus-dependent cognitive deficits.

Conclusions:

  • Metabolic reprogramming is critical for regulating M1 microglial polarization and neuroinflammation in PNDs.
  • Targeting microglial metabolism presents a promising therapeutic avenue for managing PNDs.

Related Concept Videos